Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast for Acute Gouty Arthritis
NCT00997581Phase 2Withdrawn
- Sponsor
- Dartmouth Health
- Start
- Apr 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of apremilast in gout (2 arms), sponsored by Dartmouth Health. Primary endpoints: Subject-reported number of swollen joints at Day 21, Subject-reported number of tender joints at Day 21 and 5 more. Planned start Apr 2010; status: withdrawn.
02
Drugs
apremilast
03
Conditions
gout
Beyond the preview
Go deeper on NCT00997581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00997581.